Literature DB >> 15084919

High-grade neuroendocrine carcinoma of the lung presenting an unusual spread mimicking pleural mesothelioma associated with dermatomyositis.

Yukiko Murakami1, Kenji Kanazawa, Kaoru Okuno, Shuji Maekawa, Yasuaki Matsuda, Yoshitomo Miyamoto, Yoshihiro Nishimura, Naoki Kanomata, Chiho Ohbayashi, Masayoshi Hashimoto, Hozuka Akita.   

Abstract

Neuroendocrine tumors of the lung comprise a heterogeneous group of tumors that represents a spectrum of disease from typical carcinoid tumors to the high-grade neuroendocrine carcinomas (large-cell neuroendocrine carcinomas and small-cell carcinomas). The high-grade neuroendocrine carcinomas are characterized by early metastasis and poor prognosis. The peripheral location and especially the massive pleural spread are rare for a high-grade neuroendocrine carcinoma. We report a case in which a high-grade neuroendocrine carcinoma, associated with dermatomyositis, presented an unusual pattern of progression, mimicking malignant pleural mesothelioma on diagnostic imaging.

Entities:  

Mesh:

Year:  2004        PMID: 15084919     DOI: 10.1097/00000441-200404000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Fatal hemothorax caused by pseudomesotheliomatous carcinoma of the lung.

Authors:  Petur Snaebjornsson; Cornelis G Vos; Koen J Hartemink; Rutger J Lely; Setareh M Samii; Katrien Grünberg; Marinus A Paul
Journal:  Patholog Res Int       Date:  2011-06-27

2.  Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Authors:  Reina Takashima; Kazufumi Takamatsu; Yutaka Shinkawa; Masato Yagita; Motonari Fukui; Masaaki Fujita
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

3.  Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.

Authors:  Andrew J Beel; David S Demos; Alfred Chung; Charles Liao; Natalie S Lui
Journal:  J Cardiothorac Surg       Date:  2018-02-07       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.